Newsfeed
Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.
Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.
This demo serves a captured snapshot of the feed, not a live connection to the sources.
PubMed Central · Aug 16, 2026
Biomarkers of Hypercoagulability and Thromboinflammation in Cervical Cancer-Associated Thrombosis: A Systematic Review with Translational Insights from Breast Cancer.
Read at PubMed CentralPubMed Central · Aug 16, 2026
Association Between Dietary Total Fat and Cholesterol Intake and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Cohort and Case-Control Studies.
Read at PubMed CentralPubMed Central · Aug 16, 2026
Deep Learning-Assisted Accuracy Improvement in Bladder Cancer Staging of Spectrum-Aided Visual Enhanced Cystoscopy Images.
Read at PubMed CentralPubMed Central · Aug 16, 2026
Race-Associated EGFR and KRAS Mutation Profiles in Lung Adenocarcinoma.
Read at PubMed CentralPubMed Central · Aug 15, 2026
How low do you need to go? Association between various prostate-specific antigen response measures and clinical outcomes in metastatic castration-sensitive prostate cancer in the Veterans Health Administration data.
Read at PubMed CentralPubMed Central · Aug 15, 2026
The past, present, and future treatment of BRAF(V600)-mutant metastatic colorectal cancer: A comprehensive review.
Read at PubMed CentralPubMed Central · Aug 15, 2026
Chitosan-PEG Nanoparticles for Co-Delivery of Paclitaxel and KRAS G12D-Directed siRNA to Pancreatic Cancer Cells.
Read at PubMed CentralPubMed Central · Aug 15, 2026
Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.
Read at PubMed CentralPubMed Central · Aug 15, 2026
A Small Natural Molecule Targeting IL-23/IL-17 Axis Exerts Dual Effects on T-Cell Function and Breast Cancer Cell Migration.
Read at PubMed CentralPubMed Central · Aug 15, 2026
Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions.
Read at PubMed CentralPubMed Central · Aug 15, 2026
N-Alkylated Monoterpene Indole Alkaloid Derivatives as Chemotherapy Adjuvants That Overcome P-glycoprotein-Mediated Multidrug Resistance in Cancer Cells, Spheroids and Patient-Derived Colorectal Cancer Organoids.
Read at PubMed CentralPubMed Central · Aug 15, 2026
10-HDA Suppresses the Growth of Gastric Cancer Cells Through Inducing Apoptosis and G0/G1 Cell Cycle Arrest.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Combination of PD-1 inhibitor and chemotherapy for subcutaneous soft-tissue metastasis in postoperative non-small cell lung cancer: A case report.
Read at PubMed CentralPubMed Central · Aug 14, 2026
MTA1 Regulates EMT and BRAF Signaling Networks in Canine Urothelial Carcinoma.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Bidirectional phenotypic transition in macrophages influences triple-negative breast cancer cell immune evasive patterns and response to chemotherapies in a co-culture spheroid model.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Prognostic significance of androgen receptor expression in breast cancer patients undergoing neoadjuvant chemotherapy: A retrospective cohort study.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Postoperative cutaneous metastasis of breast cancer with phenotypic conversion to triple-negative subtype: A case report.
Read at PubMed CentralPubMed Central · Aug 14, 2026
Durvalumab plus Paclitaxel, with or without Capivasertib or Oleclumab, in Patients with Locally Advanced/Metastatic Triple-Negative Breast Cancer.
Read at PubMed Central